Kazuo Nakamura
Fortuna: 137 965 $ al 31/07/2026
Fortuna: 137 965 $ al 31/07/2026
Kazuo Nakamura is the founder of CMIC Holdings Co., Ltd., which was founded in 1985.
He is currently the Chairman & Chief Executive Officer of CMIC Holdings Co., Ltd. He is also the founder of CMIC (Beijing) Co., Ltd., where he currently holds the position of Chairman since 2004.
In addition, Mr. Nakamura has previously worked as a Director at Perseus Proteomics, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PERSEUS PROTEOMICS, INC. 0,82 % | 30/09/2025 | 151.500 ( 0,82 % ) | 137 965 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
CMIC (Beijing) Co., Ltd.
CMIC (Beijing) Co., Ltd. BiotechnologyHealth Technology Provides clinical operational services | Presidente | 01/07/2004 |
| Empresas | Cargo | Fin |
|---|---|---|
| CMIC HLDG | Director Ejecutivo | - |
| PERSEUS PROTEOMICS INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
CMIC Holdings Co., Ltd.
CMIC Holdings Co., Ltd. BiotechnologyHealth Technology Operates as a contract research firm that helps drug companies to run clinical trials | Health Technology |
Perseus Proteomics, Inc.
Perseus Proteomics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets antibody-based therapeutics and diagnostics | Health Technology |
CMIC (Beijing) Co., Ltd.
CMIC (Beijing) Co., Ltd. BiotechnologyHealth Technology Provides clinical operational services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.